Article
Serum CA 19-9 levels as a diagnostic marker in cystic fibrosis patients with borderline sweat tests.
Clinical and experimental medicine - 1 Sept 2003
Augarten A, Berman H, Aviram M, Diver-Habber A, Akons H, Ben Tur L, Blau H, Kerem E, Rivlin J, Katznelson D, Szeinberg A, Kerem B-S, Theodor L, Paret G, Yahav Y
Abstract excerpt
Patients with normal or borderline sweat tests present a diagnostic challenge. In spite of the availability of genetic analysis and measurement of nasal potential difference, there is still uncertainty in diagnosing cystic fibrosis in some patients. CA 19-9 is a tumor-associated antigen whose levels were previously found to be elevated in some cystic fibrosis patients. We investigated whether serum CA 19-9 levels...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.